SCHEMBL17851920

SCHEMBL17851920

CC1(C)c2ccc(-c3ccc4oc5ccc(-c6c7ccccc7c(-c7ccc8oc9ccccc9c8c7)c7ccccc67)cc5c4c3)cc2-c2ccc3ccccc3c21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.36
ALDH1A1 P00352 7/20 0.36
MAPT P10636 5/20 0.36
HPGD P15428 4/20 0.36
KMT2A Q03164 4/20 0.36
MEN1 O00255 3/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
CASP3 P42574 1/20 0.34
SENP7 Q9BQF6 1/20 0.34
SENP6 Q9GZR1 1/20 0.34
HSP90AA1 P07900 1/20 0.34
HSP90AB1 P08238 1/20 0.34
PGR P06401 1/20 0.33
CHEK2 O96017 1/20 0.32
ESR1 P03372 1/20 0.32
POLB P06746 1/20 0.32
MAOB P27338 1/20 0.32
TSHR P16473 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17851874 0.99 KDM4E (0.37) KDM4EALDH1A1MAPTHPGDKMT2A
SCHEMBL17851895 0.98 KDM4E (0.35) KDM4EALDH1A1MAPTHPGDKMT2A
SCHEMBL17851869 0.98 KDM4E (0.35) KDM4EALDH1A1MAPTHPGDKMT2A
SCHEMBL17851899 0.98 KDM4E (0.35) KDM4EALDH1A1MAPTHPGDKMT2A
SCHEMBL17851872 0.98 PLA2G2A (0.35) KDM4EALDH1A1MAPTHPGDKMT2A
SCHEMBL17851901 0.98 PLA2G2A (0.35) KDM4EALDH1A1MAPTHPGDKMT2A
SCHEMBL17851877 0.98 PLA2G2A (0.35) KDM4EALDH1A1MAPTHPGDKMT2A
SCHEMBL17851861 0.98 PLA2G2A (0.35) KDM4EALDH1A1MAPTHPGDKMT2A
SCHEMBL17851881 0.97 KDM4E (0.35) KDM4EALDH1A1MAPTHPGDKMT2A
SCHEMBL17851865 0.96 PLA2G2A (0.34) KDM4EALDH1A1MAPTHPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160181542-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2016-06-23 US disclosed
US-20160181542-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2016-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160181542-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME L1CAM, H1-10, H1-0 KDM4E 1674/4885ALDH1A1 605/4885MAPT 4639/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.